Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony L McCall

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Current Diabetes Reports|January 5, 2008
Does a weight loss medicine make sense for obese type 2 diabetes? New information on endocannabinoid blockersAnthony L McCall
Current Diabetes Reports|September 10, 2008
Does the method of obtaining glycemic control influence cardiovascular outcomes?Anthony L McCall
Neurobiology of Aging|October 4, 2005
Altered glycemia and brain-update and potential relevance to the aging brainAnthony L McCall
Current Diabetes Reports|November 2, 2006
What to inject when oral agents fail?Anthony L McCall
Current Diabetes Reports|January 12, 2011
What's wrong with too low? Is hypoglycemia a marker or a cause of CVD and mortality risk?Anthony L McCall
Current Diabetes Reports|April 29, 2010
Is there a magic diet? Studying the balance of macronutrients needed for best weight lossAnthony L McCall
Endocrinology and Metabolism Clinics of North America|May 12, 2012
Insulin therapy and hypoglycemiaAnthony L McCall
International Review of Neurobiology|November 8, 2002
Diabetes mellitus and the central nervous systemAnthony L McCall
Current Diabetes Reports|October 2, 2009
When is evidence of lack of harm enough? Has the rosiglitazone controversy ended?Anthony L McCall
Current Diabetes Reports|September 17, 2003
Reducing CVD risk in type 2 DMAnthony L McCall
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Current Diabetes Reports|January 5, 2008
Does a weight loss medicine make sense for obese type 2 diabetes? New information on endocannabinoid blockersAnthony L McCall
Current Diabetes Reports|September 10, 2008
Does the method of obtaining glycemic control influence cardiovascular outcomes?Anthony L McCall
Neurobiology of Aging|October 4, 2005
Altered glycemia and brain-update and potential relevance to the aging brainAnthony L McCall
Current Diabetes Reports|November 2, 2006
What to inject when oral agents fail?Anthony L McCall
Current Diabetes Reports|January 12, 2011
What's wrong with too low? Is hypoglycemia a marker or a cause of CVD and mortality risk?Anthony L McCall
Current Diabetes Reports|April 29, 2010
Is there a magic diet? Studying the balance of macronutrients needed for best weight lossAnthony L McCall
Endocrinology and Metabolism Clinics of North America|May 12, 2012
Insulin therapy and hypoglycemiaAnthony L McCall
International Review of Neurobiology|November 8, 2002
Diabetes mellitus and the central nervous systemAnthony L McCall
Current Diabetes Reports|October 2, 2009
When is evidence of lack of harm enough? Has the rosiglitazone controversy ended?Anthony L McCall
Current Diabetes Reports|September 17, 2003
Reducing CVD risk in type 2 DMAnthony L McCall
Pageof 4